Abstract:Abstract Background In order to complete the physiological function of postovulatory repair during repeated ovulation, the ovarian surface epithelium (OSE) not only has to undergo epithelial-mesenchymal transition (EMT), but also possess the properties of somatic stem-like cells. However, there is no evidence to indicate that both EMT alteration and stemness acquisition are linked to epithelial ovarian carcinomas.Methods In this study, we established a cell model of spontaneous oncogenic transformation of mouse OSE (MOSE). The cell proliferation was assessed using clonogenic survival and soft agar. The self-renewal of cancer stem-like cells (CSCs) was determined by spheroid culture. CD44 + /CD117 + cells were analyzed using flow cytometer. The PCR array was used to determine the EMT-related mRNA level. Expression of pan-keratin, vimentin, E-cadherin, Snail1 and Slug were detected using western-blotting and immunofluorescences, respectively. The tumorigenesis were monitored by limiting dilution assay in vitro and in vivo .Results Based on morphological change, chromosomal number and proliferating ability, we defined three sequential stages of transformed cells as early, intermediate and late MOSE cells, respectively. We found that MOSE cells had dual characteristics of not only epithelial but mesenchymal nature as well. Over time, MOSE cells spontaneously developed characteristics of malignant cells and generated tumor nodules expressing both Pan-keratin and Vimentin. Furthermore, we found that the neoplastic transformation of MOSE was accompanied by continuous EMT-inducing signals including Snail1 and Slug. Concurrently, the increase of CD44 + /CD117 + cells and their self-renewal ability were associated with the progression of spontaneous neoplastic transformation of MOSE cells in vitro. Conclusion These results indicated that both EMT alteration and stemness acquisition were closely correlated with the spontaneous malignant progression of MOSE cells. Our findings provide new insights into the future to combat epithelial ovarian carcinomas.

Smad7 maintains epithelial phenotype of ovarian cancer stem-like cells and supports tumor colonization by mesenchymal-epithelial transition.

MicroRNA-182 Targets SMAD7 to Potentiate TGFβ-induced Epithelial-Mesenchymal Transition and Metastasis of Cancer Cells.

Cyclin D1 Affects Epithelial–mesenchymal Transition in Epithelial Ovarian Cancer Stem Cell-Like Cells

The Role of SMAD7 in the Epigenetic Regulation of TGF‐β Targets in the Metastasis of Ovarian Cancer

TGFβ and EGF synergistically induce a more invasive phenotype of epithelial ovarian cancer cells.

Stat3-coordinated Lin-28–let-7–HMGA2 and miR-200–ZEB1 circuits initiate and maintain oncostatin M-driven epithelial–mesenchymal transition

Myeloid-derived Suppressor Cells Promote Epithelial Ovarian Cancer Cell Stemness by Inducing the CSF2/p-STAT3 Signalling Pathway.

Spontaneous malignant transformation of ovarian surface epithelial cells correlates with EMT alteration and stemness acquisition

A FXYD5/TGF‑β/SMAD Positive Feedback Loop Drives Epithelial‑to‑mesenchymal Transition and Promotes Tumor Growth and Metastasis in Ovarian Cancer.

The Activation of Microrna-520H–associated TGF-β1/c-Myb/Smad7 Axis Promotes Epithelial Ovarian Cancer Progression

Transformation of Epithelial Ovarian Cancer Stemlike Cells into Mesenchymal Lineage Via EMT Results in Cellular Heterogeneity and Supports Tumor Engraftment

Correction To: MDM2 Promotes Epithelial–mesenchymal Transition and Metastasis of Ovarian Cancer SKOV3 Cells

MicroRNA-7 Inhibits Tumor Metastasis and Reverses Epithelial-Mesenchymal Transition Through AKT/ERK1/2 Inactivation by Targeting EGFR in Epithelial Ovarian Cancer

Molecular Signaling of the Epithelial to Mesenchymal Transition in Generating and Maintaining Cancer Stem Cells

Transition Breast Cancer and Confers Epithelial-Mesenchymal HOXB 7 , a Homeodomain Protein , Is Overexpressed in Updated

IL-6 regulates epithelial ovarian cancer EMT, invasion, and metastasis by modulating Let-7c and miR-200c through the STAT3/HIF-1α pathway

MiR-424-5p participates in esophageal squamous cell carcinoma invasion and metastasis via SMAD7 pathway mediated EMT

MicroRNA-200c overexpression inhibits tumorigenicity and metastasis of CD117+CD44+ ovarian cancer stem cells by regulating epithelial-mesenchymal transition

MicroRNA-7 inhibits tumor metastasis and reverses epithelial-mesenchymal transition through AKT/ERK1/2 inactivation by targeting EGFR in epithelial ovarian cancer.

Notch and TGFβ form a positive regulatory loop and regulate EMT in epithelial ovarian cancer cells.

SMAD7 Sustains XIAP Expression and Migration of Colorectal Carcinoma Cells